A detailed history of Verition Fund Management LLC transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 29,305 shares of FLGT stock, worth $852,775. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,305
Previous 32,747 10.51%
Holding current value
$852,775
Previous $651,000 1.69%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$17.18 - $22.6 $59,133 - $77,789
-3,442 Reduced 10.51%
29,305 $662,000
Q2 2025

Aug 14, 2025

SELL
$16.86 - $21.81 $757,502 - $979,901
-44,929 Reduced 57.84%
32,747 $651,000
Q1 2025

May 15, 2025

BUY
$15.28 - $18.95 $1.19 Million - $1.47 Million
77,676 New
77,676 $1.31 Million
Q1 2024

May 14, 2024

BUY
$21.55 - $29.29 $24,653 - $33,507
1,144 Added 10.31%
12,244 $265,000
Q4 2023

Feb 14, 2024

BUY
$23.64 - $30.27 $262,404 - $335,997
11,100 New
11,100 $320,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $881M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.